| Filed On | Filing |
|---|---|
| 17 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | 13F-HR |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 29 Jun 2026 |
Form 4: Clark James David, SVP, Cont & Chief Acct Officer
Gave up 454 shares to cover exercise price or tax ($41.3K) |
| 23 Jun 2026 | 11-K |
| 01 Jun 2026 |
Form 4: Newman Brian, EVP, Chief Financial Officer
Gave up 2,478 shares to cover exercise price or tax ($225K) |
| 01 Jun 2026 |
Form 4: Compton-Phillips Amy, EVP, Chief Medical Officer
Gave up 7,618 shares to cover exercise price or tax ($693K) |
| 22 May 2026 | 144 |
| 22 May 2026 |
Form 4: Aguirre Fernando, Director
Returned 30,437 shares to the issuer ($2.85M) · Returned 1,563 shares to the issuer ($146K) |
| 22 May 2026 | S-3ASR |
| 22 May 2026 | S-8 |
| 21 May 2026 |
Form 4: Robbins Larry, Director
Sold 1,983,538 shares ($187M) · Sold 1,018,000 shares ($95.5M) · Sold 370,462 shares ($34.6M) · 1 more |
| 21 May 2026 | 144 |
| 18 May 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 15 May 2026 |
Form 4: Gallina John E, Director
Granted 1,447.5039 Deferred Stock Units ($141K) |
| 15 May 2026 |
Form 4: Mahoney Michael F, Director
Granted 1,737.0046 Deferred Stock Units ($169K) |
| 15 May 2026 |
Form 4: Aguirre Fernando, Director
Received 1,563 shares as a grant or award ($152K) |
| 15 May 2026 |
Form 4: Balser Jeffrey R., Director
Received 2,058 shares as a grant or award ($200K) |
Loading...
